EUVIMEDEUVIMED entdecken
Crossref

Incidence Trends of Melanoma of the Lower Limbs and Hips in the United States: A Surveillance, Epidemiology, and End Results Analysis 2000-2019

Solange N Walz, Jerome Martineau, Matteo Scampa, Srinivas Madduri, Daniel F Kalbermatten, Carlo M Oranges

Anticancer Research · 2024

DOI: 10.21873/anticanres.16807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Solange N Walz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Reconstructive, and Aesthetic Surgery, Geneva University Hospitals, Geneva University, Geneva, Switzerland. Hauptthemen laut MEDLINE: Melanoma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: No specific studies on the changes in the incidence of melanoma in the lower limbs and hips have been performed. This article aimed to examine trends in incidence rates of melanoma of the lower extremities in the U.S. PATIENTS AND METHODS: Data from the SEER program provided by the National Cancer Institute were used to examine trends in melanoma incidence from 2000 to 2019. Data analysis was performed from October to December 2022. RESULTS: A total of 192,327 cases of melanoma of the lower limbs and hips were diagnosed from 2000 to 2019 and included in our study. The incidence rate increased from 9.78 to 13.65 cases per 100,000 person-year and by an average annual percent change (AAPC) of 2% (95%CI=1.4-2.9%). The incidence increased by an AAPC of 2.1% in men and 1.7% in women. The incidence among people under 50 remained stable but increased among those over 50 years. Localized stage disease was the only stage where a continuously increasing incidence was observed, with an AAPC of 1.7% (95%CI=0.9-2.5%). Lentiginous melanoma showed the highest incidence trend rate with an AAPC of 2.3% (95%CI=1.0-3.5%). CONCLUSION: The incidence rate of melanoma in the lower limbs and hips increased between 2000 and 2019, with a higher incidence in men, reversing the previously described trend of higher incidence among women. However, incidence among people under 50 remained stable, suggesting the efficacy of prevention campaigns in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMaleHumansFemaleUnited StatesIncidenceSEER ProgramNational Cancer Institute (U.S.)Lower Extremity

Stichwörter der Autor:innen

General dermatologyclinical dermatologyepidemiological researchlower limbs and hipsmelanomaoncologysurgery

Autor:innen und Institutionen

  • Department of Plastic, Reconstructive, and Aesthetic Surgery, Geneva University Hospitals, Geneva University, Geneva, Switzerland.
  • Bioengineering and Neuroregeneration Laboratory, Department of Surgery, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
  • Department of Plastic, Reconstructive, and Aesthetic Surgery, Geneva University Hospitals, Geneva University, Geneva, Switzerland; carlo.oranges@hcuge.ch.

Zitieren

APA

Walz, S. N., Martineau, J., Scampa, M., Madduri, S., Kalbermatten, D. F., & Oranges, C. M. (2024). Incidence Trends of Melanoma of the Lower Limbs and Hips in the United States: A Surveillance, Epidemiology, and End Results Analysis 2000-2019. Anticancer Research. https://doi.org/10.21873/anticanres.16807

Vancouver

Walz SN, Martineau J, Scampa M, Madduri S, Kalbermatten DF, Oranges CM. Incidence Trends of Melanoma of the Lower Limbs and Hips in the United States: A Surveillance, Epidemiology, and End Results Analysis 2000-2019. Anticancer Research. 2024. doi:10.21873/anticanres.16807

BibTeX
@article{Walz2024,
  author = {Walz, Solange N and Martineau, Jerome and Scampa, Matteo and Madduri, Srinivas and Kalbermatten, Daniel F and Oranges, Carlo M},
  title = {Incidence Trends of Melanoma of the Lower Limbs and Hips in the United States: A Surveillance, Epidemiology, and End Results Analysis 2000-2019},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16807}
}
Kostenlos starten →